Unipharm, Inc.   Report issue

For profit Phase 2 Phase 4
Founded: New York MD United States (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2005
NCT00422617
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. | UNIPHARMA. Universal Pharmaceutical Industries

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Anemia, Iron-Deficiency (Phase 4)

Communicable Diseases (Phase 2)

Deficiency Diseases (Phase 4)

Fever (Phase 4)

Infections (Phase 4)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8